Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
618385-01-6
Purity
95%
Vorapaxar inhibits platelet aggregation through the reversible antagonism of protease-activated receptor 1. It is used to reduce thrombotic cardiovascular events in patients with a history of myocardial infarction or peripheral arterial disease.
Properties
Name
Vorapaxar
Smiles
CCOC(=O)N[C@@H]1CC[C@H]2[C@H](/C=C/C=3C=CC(=CN3)C=4C=CC=C(F)C4)[C@@H]5[C@@H](C)OC(=O)[C@@H]5C[C@@H]2C1
Targets
Please log in to see this information
SDS
Sch 530348 | vorapaxar
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$37
2 mg
$39
5 mg
$41
10 mg
$43
15 mg
$45
20 mg
$48
25 mg
$53
30 mg
$56
35 mg
$59
40 mg
$61
45 mg
$64
50 mg
$66
75 mg
$69
100 mg
$POA
Quantity
1
Total amount
$ 41
Sch 530348 | vorapaxar
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.
CAS:705260-08-8
0